Control Bionics Limited

Equities

CBL

AU0000114183

Advanced Medical Equipment & Technology

Delayed Australian S.E. Other stock markets 09:11:16 10/05/2024 am IST			5-day change	1st Jan Change
0.05 ^AUD	+2.04%		+16.28%	+8.70%

02:22am	Control Bionics Appoints Corporate Advisor	MT
09/05	Control Bionics Appoints CFO	MT

Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023

June 13, 2023 at 11:40 am IST

Control Bionics Limited provided revenue guidance for the year ended 30 June 2023. The revenue for the year ended 30 June 2023 is expected to be approximately $5.3 million, a more than 20% increase in the revenue of $4.4 million for the year ended 30 June 2022.

Latest news about Control Bionics Limited

Control Bionics Appoints Corporate Advisor	05:52am	MT
Control Bionics Appoints CFO	09/05	MT
Control Bionics Signs Multiple Award Schedule Contract with US Government	09/05	MT
Australian Shares Jump to More than Three-Week High as Central Bank Holds Rates	07/05	MT
Control Bionics Signs MoU for Japan Launch of NeuroStrip; Shares Up 13%	07/05	MT
Control Bionics Registers Wearable Device with UK Medical Regulator	08/03	MT
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02	CI
Control Bionics Secures US Grant Funding to Develop Autonomous Wheelchair Device	24/01	MT
Control Bionics Raises AU$1 Million Via Shortfall Placement	19/01	MT
Control Bionics Receives AU$480,500 R&D Tax Rebate	22/11	MT
Control Bionics Launches NeuroStrip Wearable Device	12/23/12	MT
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023	13/23/13	CI
Control Bionics Limited Announces Unaudited Sales Results for the Month Ended May 2023	13/23/13	CI
Control Bionics Limited Announces Directorate Changes	04/23/04	CI
Control Bionics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23/23/23	CI
Investments in Indonesia's nickel industry	06/23/06	RE
Control Bionics Limited Announces Board Changes	19/23/19	CI
Control Bionics Limited Announces CEO Changes	19/23/19	CI
6,933,538 Options of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022.	07/22/07	CI
42,818,796 Ordinary Shares of Control Bionics Limited are subject to a Lock-Up Agreement Ending on 7-DEC-2022.	07/22/07	CI
Control Bionics CEO Resigns	15/22/15	MT
Control Bionics Limited Announces Resignation of Rob Wong as CEO	15/22/15	CI
Control Bionics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	24/22/24	CI
Control Bionics Limited Auditor Raises 'Going Concern' Doubt	24/22/24	CI

Chart Control Bionics Limited

Duration

Period

More charts

Company Profile

Control Bionics Limited is a medical device company engaged in the development, commercialization and sale of assistive communications technology systems within the disability sector. It assists patients whose ability to communicate verbally or through text and social media is compromised by illnesses, such as motor neuron disease, amyotrophic lateral sclerosis, and others. Its NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography output. This output is then sent wirelessly through the NeuroNode to a personal computer, enabling speech and other computer-controlled functions, such as email and texting. Its core systems include NeuroNode Trilogy, NeuroNode Duo, Eye-gaze Duo, and DROVE. Its technology is integrated with eye-gaze technology, whereby the eye gaze enables a cursor to be moved on a computer screen, driven like a mouse, and the NeuroNode acts like the mouse button.

Sector

Advanced Medical Equipment & Technology

Calendar

21/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
CONTROL BIONICS LIMITED	+8.70%	5.63M
SARTORIUS AG	-16.33%	18.62B
QUIDELORTHO CORPORATION	-42.18%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.02%	1.94B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	+0.39%	1.68B
BIOTAGE AB	+27.15%	1.26B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.70%	1.03B
CONTEC MEDICAL SYSTEMS CO.,LTD	-18.27%	938M
REVENIO GROUP OYJ	+0.66%	783M
VAREX IMAGING CORPORATION	-25.07%	628M

Medical Diagnostic & Testing Equipment